Literature DB >> 21165348

Familial interstitial pulmonary fibrosis: a large family with atypical clinical features.

Ranji Chibbar1, John A Gjevre, Francis Shih, Heather Neufeld, Edmond G Lemire, Derek A Fladeland, Donald W Cockcroft.   

Abstract

A large kindred of familial pulmonary fibrosis is reported. Six members from the first two generations of this particular kindred were described more than 40 years previously; six more individuals from the third and fourth generations have also been evaluated. The proband, now 23 years of age, has mild disease; the other 11 documented affected family members all died from their disease at an average age of 37 years (range 25 to 50 years). The pathology was that of usual interstitial pneumonia, as is typical in idiopathic pulmonary fibrosis. However, the initial radiographic pattern in many of these individuals was upper lobe and nodular and, along with the young age, was atypical for idiopathic pulmonary fibrosis. Several genetic abnormalities have been associated with familial pulmonary fibrosis. The present study examined the genes coding for surfactant protein-C, ATPbinding cassette protein A3 and telomerase, and found no abnormalities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21165348      PMCID: PMC3006149          DOI: 10.1155/2010/591523

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  21 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Mutations in the surfactant protein C gene associated with interstitial lung disease.

Authors:  Lawrence M Nogee; Alston E Dunbar; Susan Wert; Frederic Askin; Aaron Hamvas; Jeffrey A Whitsett
Journal:  Chest       Date:  2002-03       Impact factor: 9.410

Review 3.  Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings.

Authors:  Carolina Althoff Souza; Nestor L Müller; Julia Flint; Joanne L Wright; Andrew Churg
Journal:  AJR Am J Roentgenol       Date:  2005-12       Impact factor: 3.959

4.  Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred.

Authors:  Alan Q Thomas; Kirk Lane; John Phillips; Melissa Prince; Cheryl Markin; Marcy Speer; David A Schwartz; Radhika Gaddipati; Annis Marney; Joyce Johnson; Richard Roberts; Jonathan Haines; Mildred Stahlman; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

5.  Structure and expression of the pulmonary surfactant protein SP-C gene in the mouse.

Authors:  S W Glasser; T R Korfhagen; M D Bruno; C Dey; J A Whitsett
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

6.  Familial idiopathic pulmonary fibrosis: clinical features and outcome.

Authors:  Hong-Lyeol Lee; Jay H Ryu; Michael H Wittmer; Thomas E Hartman; James F Lymp; Henry D Tazelaar; Andrew H Limper
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

7.  Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis.

Authors:  Rajni Chibbar; Francis Shih; Monica Baga; Emina Torlakovic; Kumar Ramlall; Robert Skomro; Donald W Cockcroft; Edmond G Lemire
Journal:  Mod Pathol       Date:  2004-08       Impact factor: 7.842

8.  Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.

Authors:  Yongyu Wang; Phillip J Kuan; Chao Xing; Jennifer T Cronkhite; Fernando Torres; Randall L Rosenblatt; J Michael DiMaio; Lisa N Kinch; Nick V Grishin; Christine Kim Garcia
Journal:  Am J Hum Genet       Date:  2008-12-18       Impact factor: 11.025

9.  Familial fibrocystic pulmonary dysplasia: a detailed family study.

Authors:  A G Adelman; G Chertkow; R C Hayton
Journal:  Can Med Assoc J       Date:  1966-09-17       Impact factor: 8.262

10.  ABCA3 gene mutations in newborns with fatal surfactant deficiency.

Authors:  Sergey Shulenin; Lawrence M Nogee; Tarmo Annilo; Susan E Wert; Jeffrey A Whitsett; Michael Dean
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

View more
  5 in total

1.  Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua Solomon; David Sprunger; Kevin K Brown
Journal:  Respir Med       Date:  2012-01-31       Impact factor: 3.415

2.  Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence.

Authors:  Tianju Liu; Francina Gonzalez De Los Santos; Yuyue Zhao; Zhe Wu; Andrew E Rinke; Kevin K Kim; Sem H Phan
Journal:  J Biol Chem       Date:  2019-04-18       Impact factor: 5.157

3.  Telomerase and telomere length in pulmonary fibrosis.

Authors:  Tianju Liu; Matthew Ullenbruch; Yoon Young Choi; Hongfeng Yu; Lin Ding; Antoni Xaubet; Javier Pereda; Carol A Feghali-Bostwick; Peter B Bitterman; Craig A Henke; Annie Pardo; Moises Selman; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

4.  Consequences of telomere dysfunction in fibroblasts, club and basal cells for lung fibrosis development.

Authors:  Paula Martínez; Giuseppe Bosso; Sergio Piñeiro-Hermida; Juana María Flores; Sarita Saraswati; Jane Connor; Raphael Lemaire; Maria A Blasco
Journal:  Nat Commun       Date:  2022-10-06       Impact factor: 17.694

5.  Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging.

Authors:  Sergio Piñeiro-Hermida; Chiara Autilio; Paula Martínez; Fátima Bosch; Jesús Pérez-Gil; Maria A Blasco
Journal:  J Cell Biol       Date:  2020-10-05       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.